Dr. Reiman is Executive Director of the Banner Alzheimer's Institute, Chief Executive Officer of Banner Research, Professor and Clinical Director of Neurogenomics at the Translational Genomics Research Institute, Professor of Psychiatry at the University of Arizona, University Professor of Neuroscience at Arizona State University, and Director of the Arizona Alzheimer's Consortium. He and his Banner Alzheimer's Institute colleagues Drs. Pierre Tariot and Jessica Langbaum lead the Alzheimer's Prevention Initiative (API), which has helped to introduce a new era in Alzheimer's prevention research.
Dr. Reiman received his undergraduate and medical degrees at Duke University and his Psychiatry Residency training at Duke and Washington University in St. Louis.
Launching his research career as a resident and faculty member under Dr. Marcus Raichle, he and his colleagues introduced brain imaging paradigms and image analysis techniques that have had a profound impact on the study of the human mind and brain.
Dr. Reiman is internationally recognized for his pioneering contributions in brain imaging, genomics, and the cognitive and behavioral neurosciences, the unusually early detection and tracking of Alzheimer's disease, and the accelerated evaluation of Alzheimer's prevention therapies. He and his colleagues helped establish a new national standard of dementia care and they have led efforts to develop multi-institute and multi-disciplinary efforts toward developing and obtaining approval for new Alzheimer's therapeutics by 2025.
Dr. Reiman an author of more than 600 publications, a principal investigator of several large NIH grants, and a recipient of the Potamkin Prize.
